BCKDHB
BCKDHB (branched chain keto acid dehydrogenase E1 subunit beta, also known as OVD1B) is the beta subunit of the E1 component of the mitochondrial branched-chain alpha-ketoacid dehydrogenase complex. It acts in the catabolism of the branched-chain amino acids valine, leucine and isoleucine. Browse Assay Genie's current range of BCKDHB research reagents below, or read on for the biology behind the target.
BCKDHB forms the heterotetrameric E1 subunit of the mitochondrial branched-chain alpha-ketoacid dehydrogenase (BCKD) complex together with BCKDHA. The BCKD complex catalyses the multi-step oxidative decarboxylation of alpha-ketoacids derived from valine, leucine and isoleucine, producing CO2 and acyl-CoA, which is then used to produce energy.
The E1 subunit catalyses the first step of this reaction, the decarboxylation of the alpha-ketoacid, which forms an enzyme-product intermediate. A reductive acylation mediated by the lipoylamide cofactor of E2 then extracts the acyl group from the E1 active site so that the next step can proceed. The enzyme is assigned EC 1.2.4.4 and sits in the mitochondrial matrix; NCBI Gene describes the complex as associated with the inner mitochondrial membrane.
The human BCKDHB gene encodes the E1 beta subunit, and alternative splicing at this locus produces multiple transcript variants. The protein is also listed as 2-oxoisovalerate dehydrogenase subunit beta, mitochondrial, and the gene was previously named branched chain keto acid dehydrogenase E1, beta polypeptide. HGNC places it in the branched chain alpha-keto acid dehydrogenase complex subunits and oxidoreductases groups. Mutations in the BCKDHB gene have been associated with maple syrup urine disease (MSUD) type 1B, which is characterised by a maple syrup odour in the urine, mental and physical retardation and feeding problems. Mouse and rat both carry a Bckdhb ortholog.
BCKDHB is a component of the complex that catabolises valine, leucine and isoleucine, making it relevant to studies of branched-chain amino acid breakdown.
Mutations in BCKDHB are associated with maple syrup urine disease type 1B, so the gene is a focus for work on this inherited disorder.
As the E1 beta subunit, BCKDHB supports the first, decarboxylation step of the BCKD complex reaction in the mitochondrial matrix.
The BCKD complex yields CO2 and acyl-CoA, which is subsequently utilised to produce energy, linking BCKDHB to mitochondrial energy metabolism.
BCKDHB is the beta subunit of the E1 component of the mitochondrial BCKD complex, partnering with BCKDHA. E1 catalyses the first step, decarboxylation of alpha-ketoacids derived from valine, leucine and isoleucine, which feeds the production of CO2 and acyl-CoA.
BCKDHB is also called OVD1B, and UniProt names the protein 2-oxoisovalerate dehydrogenase subunit beta, mitochondrial. A previous HGNC name was branched chain keto acid dehydrogenase E1, beta polypeptide. Alternative splicing of the gene gives multiple transcript variants.
Mutations in BCKDHB are associated with maple syrup urine disease type 1B, marked by a maple syrup odour in the urine, mental and physical retardation and feeding problems. Mouse and rat have Bckdhb orthologs; check the datasheet of any product for its validated reactivity.
Other BCKD complex subunits, regulators and mitochondrial enzymes of branched-chain amino acid metabolism.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P21953; product specifications from Assay Genie datasheets.